Seemal Desai, M.D., FAAD, discusses how immune system dysregulation and genetic variants intersect to trigger vitiligo development while highlighting diagnostic challenges including identifying ...

A breakthrough medication in vitiligo treatment that has been available in ... How the new medication works “[The medication is] topical ruxolitinib cream applied twice a day to the affected areas. It ...

SHENZHEN, CHINA, Oct 18, 2024 - (ACN Newswire) - China Medical System Holdings Limited (the “Group” or “CMS”) is pleased to announce that on 18 October, the first batch of prescriptions of ruxolitinib ...

which officially introduced ruxolitinib cream for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age, providing a novel treatment option ...

In Europe, ruxolitinib cream (Opzelura) is approved for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age[3]. On 2 December 2022 ...

AMSTERDAM — Treatment with ruxolitinib ... atopic dermatitis and for nonsegmental vitiligo in adults and children aged 12 years or older. Ruxolitinib cream twice daily resulted in “significant ...

People with vitiligo often need to use many medicines ... or surgery to help reverse the symptoms. Other treatments, like lotions and creams, can be applied directly to the affected areas, known ...